Skip to content
Extreme Investor Network
  • Contact Us
  • Privacy Policy

NonOpioid

FDA Greenlights Vertex’s Non-Opioid Pain Relief Drug, Journavx

January 30, 2025
FDA approves Vertex non-opioid painkiller drug Journavx

Vertex Pharmaceuticals Sets a New Standard in Pain Management with FDA Approval of Non-Opioid Painkiller In a groundbreaking moment for pain management solutions, Vertex Pharmaceuticals has received FDA approval for its innovative non-opioid painkiller, Journavx. … Read more

Categories Business News Tags drug, FDA, Greenlights, Journavx, NonOpioid, pain, Relief, Vertexs

Categories

Recent Posts

  • Ulli Schulz Explores the Evolution of 3D Design in Conversation with Render NetworkJune 13, 2025
  • Kenvue Considers Divesting Certain Skin Health and Beauty Brands, Sources ReportJune 13, 2025
  • Natural Gas Price Outlook: Stabilizes at Crucial Moving Average SupportJune 13, 2025
  • Carter Worth’s Insights on the Future Movements of Oil Prices According to the ChartsJune 13, 2025
  • Character.AI Unveils Framework for Assessing Engaging Writing ModelsJune 13, 2025
  • Analysis: Trump’s Tax Cut Bill May Hinder U.S. Critical Minerals ProjectsJune 13, 2025
  • Gold Price Outlook: Bullish Momentum and Patterns Point to New HighsJune 13, 2025
  • JBS Brazilian Meat Company Launches IPO in the U.S.June 13, 2025
  • Bank of America: S&P 500 Overvalued Across All 20 Metrics It MonitorsJune 13, 2025
  • Market Insights – June 13, 2025June 13, 2025

Archives

© 2025 Extreme Investor Network

Usermaven | Website analytics and product insights